Table 2 Outcomes for patients with carbapenem resistant pseudomonas aeruginosa
Parameter | Total (n = 124) | NCBL (n = 98) | NVL (n = 26) | P-value |
|---|---|---|---|---|
n (%) OR Median [IQR] | ||||
Primary outcomes | ||||
30- days Mortality | 53 (42.7) | 41 (41.8) | 12 (46.2) | 0.692 |
Secondary outcomes | ||||
30- days Mortality related to infection | 39 (31.5) | 29 (29.6) | 10 (38.5) | 0.387 |
Clinical cure by the end of treatment | 69 (50.0) | 53 (47.7) | 16 (59.3) | 0.283 |
Microbiological outcome | ||||
-Eradication | 48 (38.7) | 33 (33.7) | 15 (57.7) | 0.025* |
90-day infection recurrence | 70 (56.5) | 60 (61.2) | 10 (38.5) | 0.037* |
30-days hospital readmission | 29 (23.4) | 26 (26.5) | 3 (11.5) | 0.108 |
30-days readmission due to infection | 13 (10.5) | 13 (13.3) | 0 (0.0) | 0.050 |
ICU LOS (days) | 22.5 [10.5, 48] | 21 [10, 47] | 30 [14, 73] | 0.288 |
Hospital LOS (days) | 78 [32, 137.5] | 78.5 [34, 137] | 62 [25, 198] | 0.652 |